Companies
/
OpenEvidence
Artificial Intelligence
Healthtech
$12.8B
+$478.31
1,371.43%
30 days ago
$34.88
Create an account to view live offerings, pricing, and market activity.
Sign up with Augment to see the latest market activity.
Sign in to view offerings and live market activity.
OpenEvidence is a Cambridge, Massachusetts-based medical AI company providing physicians with an AI platform that retrieves and synthesizes clinical evidence at the point of care.
OpenEvidence was founded to address the significant challenge physicians face keeping pace with the enormous and continuously growing volume of published medical research, which no individual clinician could realistically read in full, by building an AI platform specifically designed to help doctors quickly find and synthesize relevant clinical evidence while actively treating patients, differentiating itself from general-purpose AI chatbots by grounding its responses specifically in peer-reviewed medical literature and emphasizing clinical accuracy and appropriate sourcing. The platform has achieved substantial adoption among practicing physicians, with health systems including Cedars-Sinai deploying OpenEvidence enterprise-wide within clinical workflows, and the company has continued expanding its product capability, including a hands-free voice interface that lets physicians query the system without needing to type while engaged in direct patient care, addressing the practical reality that clinicians often need information quickly during time-constrained patient encounters where typing a detailed query is impractical. OpenEvidence raised a $250 million Series D round in early 2026 co-led by Thrive Global and DST Global, reaching a valuation of $12 billion, reflecting substantial investor confidence in the clinical AI decision-support category as health systems increasingly look to AI tools to help manage the growing complexity and volume of medical knowledge that practicing physicians must navigate, and the company has continued to see strong activity and demand signals in secondary private markets as a notable name among healthcare-focused AI companies.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
| Company | Valuation |
|---|---|
Open Anthropic Artificial Intelligence | $1.35T |
Open OpenAI Artificial Intelligence | $1.19T |
Open Neuralink Healthtech | $51.5B |
Open Cognition AI (Devin) Artificial Intelligence | $60.4B |
Open Prometheus Artificial Intelligence | $50.2B |
Sign up with Augment to see the latest market activity.
